DIXIE RICHTER: Open Payments
NPI 1265109953 · FULTONDALE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 10 payments from 8 companies in 2025. Trend: 2023 $21 · 2024 $16 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: Ozempic, REXULTI, Rybelsus, PAXLOVID, General - Pain Management, TZIELD, GEMTESA, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
